| Trial ID: | L6217 |
| Source ID: | NCT00425009
|
| Associated Drug: |
Berberine
|
| Title: |
Therapeutic Effects of Berberine in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Berberine|DRUG: Metformin
|
| Outcome Measures: |
Primary: HbA1c at 13 weeks | Secondary: Blood glucose at 13 weeks|Blood lipids at 13 weeks
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine | Collaborators: National Institutes of Health (NIH)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
70
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-01
|
| Completion Date: |
2004-12
|
| Results First Posted: |
|
| Last Update Posted: |
2007-01-22
|
| Locations: |
Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00425009
|
